SavedAdd your journal

Journals / Sağlık Bilimlerinde İleri Araştırmalar Dergisi / 2019 / Cilt: 2 - Sayı: 3

The Importance of Long Noncoding RNAs in Cardiovascular Diseases

Kardiyovasküler Hastalıklarda Uzun Kodlamayan RNA’lar ve Sirküler RNA’ların Önemi

Hilal ŞENTÜRK
Evrim KOMURCU-BAYRAK
Pages
115–125
Publication Date
2019-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review summarizes the functional roles of lncRNAs and circRNAs and their relationships with atherosclerosis and CVDs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cardiovascular diseases (CVDs) are a leading cause of mortality and morbidity and mostly affect adults.
📊
Key Findings & Data:The main underlying mechanism of CVDs is atherosclerosis and this complex pathology is caused by the formation of fibrous plaques, the proliferation of smooth muscle cells and the migration of inflammatory cells.
💡
Conclusion & Impact:This review summarizes the functional roles of lncRNAs and circRNAs and their relationships with atherosclerosis and CVDs.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kardiyovasküler hastalıklar · uzun kodlamayan RNA · sirküler RNA

Abstract

Cardiovascular diseases (CVDs) are a leading cause of mortality and morbidity and mostly affect adults. The main underlying mechanism of CVDs is atherosclerosis and this complex pathology is caused by the formation of fibrous plaques, the proliferation of smooth muscle cells and the migration of inflammatory cells. Recent studies suggest that noncoding RNAs such as long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) have critical regulatory roles in the epigenetics of all CVDs including atherosclerosis. This review summarizes the functional roles of lncRNAs and circRNAs and their relationships with atherosclerosis and CVDs.

Özet

Kardiyovasküler hastalıklar (KVH'lar), mortalite ve morbiditenin en önemli nedeni olup çoğunlukla yetişkinlerde gözlenmektedir. KVH’ların altında yatan ana mekanizma, fibröz plakların oluşumu, düz kas hücrelerinin çoğalması ve enflamatuvar hücrelerin göçü ile meydana gelen karmaşık bir patoloji olan aterosklerozdur. Son çalışmalar, uzun kodlamayan RNA'lar (lncRNA) ve dairesel RNA'lar (circRNA) gibi protein kodlamayan RNA'ların, ateroskleroz dahil tüm KVH’ların epigenetiğinde önemli düzenleyici rollere sahip olduğunu göstermektedir. Bu derlemede, lncRNA'ların ve circRNA'ların fonksiyonel aktiviteleri ve bunların ateroskleroz ve KVH’larla olan ilişkileri özetlenmektedir.

🔖

Cite This Article

ŞENTÜRK, H., KOMURCU-BAYRAK, E. (2019). The Importance of Long Noncoding RNAs in Cardiovascular Diseases. Sağlık Bilimlerinde İleri Araştırmalar Dergisi, Cilt: 2 - Sayı: 3, 115–125. https://ajindex.com/articles/217140

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Karaarslan Z.Ö., Serin M.S. (2016): Hastalıkların tanı ve tedavi stratejilerinde miRNA ve diğer non-proteincoding RNA’lar. Mersin Univ Saglık Bilim Derg,(9)3
  2. Zhang F, Zhang R, Zhang X, Wu Y, Li X, Zhang S, Hou W, Ding Y, Tian J, Sun L, Kong X. (2018): Comprehensive analysis of circRNA expression pattern and circRNAmiRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits.Aging (Albany NY), 10(9):2266-2283
  3. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, ve ark. (2013): Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell, 152(3): 570583
  4. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, ve ark. (2014):Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res, 114(10): 1569-1575
  5. Archer K, Broskova Z, Bayoumi AS, Teoh JP, Davila A, Tang Y, ve ark. (2015): Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases. Int J Mol Sci, 16(10): 23651-23667
  6. Wang W, Wang Y, Piao H, Li B, Huang M, Zhu Z, Li D, Wang T, Xu R, Liu K. (2019): Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease. PeerJ, 7:e6831
  7. Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, et al. (2015): The landscape of long noncoding RNAs in the human transcriptome. Nat Genet., 47:199–208
  8. Scheuermann JC, Boyer LA. (2013): Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO J., 32(13): 1805-1816
  9. Bayoğlu B, Cengiz M. (2017): Kalp ve Damar Hastalıklarında Uzun Kodlanmayan RNA Transkriptlerinin Rolleri. Bezmialem Science, 5: 74-79
  10. Lee JT. (2012): Epigenetic regulation by long noncoding RNAs. Science, 338(6113): 1435-1439
  11. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, ve ark. (2007): RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316(5830): 1484-1488
  12. Sana J, Faltejskova P, Svoboda M, Slaby O. (2012) Novel classes of non-coding RNAs and cancer. J Transl Med., 10: 103
  13. Tian D, Sun S, Lee JT. (2010): The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation. Cell.,143(3): 390-403
  14. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, ve ark. (2011): Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet, 43(7): 621-629
  15. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, ve ar